Gregory Divis - Chief Executive Officer, Avadel Pharmaceuticals Plc

As of December 9, 2021


Gregory Divis Net Worth

  • Net worth is estimated to be at least $661.31K
  • Owns at least 99,100 units of Avadel Pharmaceuticals Plc stock

Gregory Divis Compensation at Avadel Pharmaceuticals Plc in 2020

  • Earned a $520,000 salary
  • Received a total compensation of $

Gregory Divis Trading

  • Largest purchase of shares was 13,000 units , worth over $101.16K on August 13, 2020
  • In total has made about 3 transactions over a year
  • Usually trades in December, with the busiest year in 2020
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

Gregory Divis Mailing Address

  • Mailing address is 10-1 Blanchardstown Corporate Park Ballycoolin Dublin L2 15 Ireland

Avadel Pharmaceuticals Plc Executive Compensation

Name
Year
Salary
Stock Awards
Option Awards
Other Earnings Plans or Compensations
Other Compensation
Other Earnings Plans or Compensations
Gregory J. Divis 2020 $520,000 - $2,246,694 $3,143,694 $23,400 $3,143,694
Gregory J. Divis 2019 $472,292 $33,300 $485,010 $1,436,262 $23,316 $1,436,262
Gregory J. Divis 2018 $417,178 - $198,500 $685,428 $23,000 $685,428
Thomas S. McHugh 2020 $385,000 - $898,678 $1,479,878 $11,400 $1,479,878
Thomas S. McHugh 2019 $33,688 - $469,600 $503,288 - $503,288
Jordan S. Dubow 2020 $368,756 - $254,604 $859,740 $236,381 $859,740
Jordan S. Dubow 2019 $293,296 - $273,258 $743,224 $10,282 $743,224
Phillandas T. Thompson 2020 $310,594 - - $850,652 $417,041 $850,652
Phillandas T. Thompson 2019 $383,400 $33,300 $103,250 $698,157 $21,780 $698,157
Phillandas T. Thompson 2018 $365,968 - - $450,378 $20,000 $450,378
No matching records found

Source: https://www.sec.gov/Archives/edgar/data/1012477/000110465921059020/tm212548-2_def14a.htm

Avadel Pharmaceuticals Plc Insider Trading

  • The most recent transaction was 4,000 units bought on September 21, 2020 by Thomas McHugh worth over $24K
  • In the last 3 years, insiders at Avadel Pharmaceuticals Plc sold an estimated value of $6.27M and bought an estimated value of $4.59M
  • The most active traders are Craig R Stapleton, Director,  Eric Ende, Director,  and Gregory Divis, Chief Executive Officer
  • Insider trading is most common in January, with the busiest year in 2017

AVADEL PHARMACEUTICALS PLC Insider Trades

Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1